ÖSTERREICHISCHE GESELLSCHAFT FÜR CHIRURGISCHE ONKOLOGIE bzw. AUSTRIAN SOCIETY OF SURGICAL ONCOLOGY (ACO-ASSO)

Pre- and postoperative chemotherapy including Bevacizumab in potentially curable metastatic colorectal Cancer (mCRC). A multicenter, prospective Phase I/II academic trial. - ACO-ASSO LM1